Skip to content
Freddy T. Nguyen, MD, PhD
Research Fellow @ Massachusetts Institute of Technology
CEO, Co-Founder @ Nine Diagnostics
Google Scholar
PubMed
ResearchGate
ORCID
Dimensions.AI
Google Scholar
PubMed
ResearchGate
ORCID
Dimensions.AI
X-twitter
Linkedin
Instagram
Facebook
Home
About
News
Press
Podcasts
Mentions
Publications
Peer-Reviewed
Reviews
Patents
White Papers
Innovation
Patents
Nine Diagnostics
Prevented Health
MIT Healthcare Innovation
MIT Hacking Racism Challenge
MIT COVID-19 Challenge
MIT Hacking Medicine
Project Prana Foundation
wePool.AI
Physician Scientist
American Physician Scientists Association
People
Home
About
News
Press
Podcasts
Mentions
Publications
Peer-Reviewed
Reviews
Patents
White Papers
Innovation
Patents
Nine Diagnostics
Prevented Health
MIT Healthcare Innovation
MIT Hacking Racism Challenge
MIT COVID-19 Challenge
MIT Hacking Medicine
Project Prana Foundation
wePool.AI
Physician Scientist
American Physician Scientists Association
People
Photonics
Fluorescence Spectroscopy
Optical Coherence Tomography
Raman Spectroscopy
Photonics
Fluorescence Spectroscopy
Optical Coherence Tomography
Raman Spectroscopy
Nanotechnology
Carbon Nanotubes
Contrast Agents
Nanotechnology
Carbon Nanotubes
Contrast Agents
Medicine
Cancer
Transfusion Medicine
Medicine
Cancer
Transfusion Medicine
Physician-scientist developing biophotonics and nano technologies for functional precision medicine to provide the right treatment to the right patient at the right time.
Cancer
Cancer
January 1, 2020
Fluorescence-based detection of protein aggregation and fiber optic-based benchtop instrument
August 6, 2024
Molecular Recognition and In Vivo Detection of Temozolomide and 5-Aminoimidazole-4-carboxamide for Glioblastoma Using Near-Infrared Fluorescent Carbon Nanotube Sensors
December 16, 2022
Emerging technologies in cancer detection
June 17, 2022
Nature Nanotechnology: A wavelength-induced frequency filtering method for fluorescent nanosensors in vivo
May 30, 2022
Nature Digital Medicine: Grass-roots entrepreneurship complements traditional top-down innovation in lung and breast cancer
January 21, 2022
2020 Beckman Symposium: From biochemical nanosensors to imaging to informatics to COVID-19 convalescent plasma – developing diagnostics and therapies for clinical medicine
November 2, 2020
Implantable Nanosensors for Human Steroid Hormone Sensing In Vivo Using a Self-Templating Corona Phase Molecular Recognition
September 16, 2020
A Fiber Optic Interface Coupled to Nanosensors: Applications to Protein Aggregation and Organic Molecule Quantification
July 15, 2020
Cancer Research: DNA-SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma
September 1, 2019
MIT News: Yearlong hackathon engages nano community around health issues Hacking Nanomedicine kicks off a series of events to develop an idea over time.
August 9, 2019
In vivo detection of drug-induced apoptosis in tumors using Raman spectroscopy
October 8, 2018
Children’s Hospital of Philadelphia – Mitochondrial Research Affinity Group Seminar
July 30, 2018
Characterization of magnetic nanoparticle-seeded microspheres for magnetomotive and multimodal imaging
July 16, 2018
2017 Class of Arnold O. Beckman Postdoctoral Fellows
June 6, 2017
MIT News: Developing rapid cancer nano sensors
May 11, 2017
MIT News: Four from MIT named 2017 Arnold O. Beckman Postdoctoral Fellows
April 24, 2017
2017 Arnold O. Beckman Postdoctoral Fellow
March 30, 2017
Freddy Nguyen Chosen for an Arnold O. Beckman Postdoctoral Fellows Award
March 30, 2017
Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy
December 14, 2016
Beckman Laser Institute Seminar: Targeted Multi-Modal Protein Microspheres for Cancer Imaging
April 28, 2016
Optical coherence tomography and targeted multi-modal protein microspheres for cancer imaging
March 18, 2015
Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors
March 17, 2015
Targeted multi-modal protein microspheres for cancer imaging
April 1, 2011
Targeted multifunctional multimodal protein-shell microspheres as cancer imaging contrast agents
February 5, 2011
Fourier Transform Light Scattering (FTLS) of Cells and Tissues
December 1, 2010
Congressionally Directed Medical Research Programs – Breast Cancer Research Program
September 1, 2010
RGD coated protein microspheres as a dual fluorescent and magnetomotive contrast agent for targeted cancer imaging with magnetomotive optical coherence tomography
April 1, 2010
Optical coherence tomography: the intraoperative assessment of lymph nodes in breast cancer
March 18, 2010
Cancer Research: Intraoperative evaluation of breast tumor margins with optical coherence tomography
November 11, 2009
Clinical feasibility of microscopically-guided breast needle biopsy using a fiber-optic probe with computer-aided detection
October 1, 2009
Optical coherence tomography (OCT) as a diagnostic tool for the real-time intraoperative assessment of breast cancer surgical margins
January 1, 2009
Coherent optical imaging and guided interventions in breast cancer: translating technology into clinical applications
April 17, 2008
Magnetic protein microspheres as dynamic contrast agents for magnetomotive optical coherence tomography
February 22, 2008
Intraoperative Needle-Based Refractive Index Measurement of ex vivo Human Breast Tissue
September 16, 2007
Optical coherence tomography: a review of clinical development from bench to bedside
September 1, 2007
Needle-based refractive index measurement using low-coherence interferometry
February 15, 2007
Portable real-time optical coherence tomography system for intraoperative imaging and staging of breast cancer
February 6, 2007
Needle-probe system for the measurement of tissue refractive index
February 6, 2007
Three-Dimensional Visualization of Lymph Node Morphology Using OCT
March 19, 2006
Optical biopsy of lymph node morphology using optical coherence tomography
October 1, 2005
Instrumentation for multi-modal spectroscopic diagnosis of epithelial dysplasia
December 1, 2003